Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00863928 · ClinicalTrials.gov registry record · NA
Effects of Perioperative B&O Suppositories on Post-op Pain and Morphine Use After Laparoscopic Prostatectomy
A NA study, sponsored by Benaroya Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
NCT00863928 is a NA study that has completed, run by Benaroya Research Institute. The registered enrollment target is 135 participants.
The verdict
NCT00863928, a NA study, has completed, sponsored by Benaroya Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
Study Summary
This study is evaluating the effect of a Belladonna and Opium suppository administered intraoperatively on post operative pain after laparoscopic radical prostatectomy for prostate cancer. This is a blinded randomized study. 50% of patients will receive the suppository, 50% of patients will not. Neither you or your surgeon will know which group you are in.
Interventions
- DRUG belladonna 16.2 mg and opium 60 mg suppository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00863928
The ClinicalTrials.gov registry entry for NCT00863928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Benaroya Research Institute, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which belladonna 16.2 mg and opium 60 mg suppository is the first listed.
NCT00863928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00863928 about?
NCT00863928 is a clinical study titled "Effects of Perioperative B&O Suppositories on Post-op Pain and Morphine Use After Laparoscopic Prostatectomy". This study is evaluating the effect of a Belladonna and Opium suppository administered intraoperatively on post operative pain after laparoscopic radical prostatectomy for prostate cancer. This is a blinded randomized study. 50% of patients will receive the suppository, 50% of patients will not. Nei...
What is the current status of trial NCT00863928?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2008-10. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00863928?
The interventions under investigation include: belladonna 16.2 mg and opium 60 mg suppository (DRUG).
Who is sponsoring clinical trial NCT00863928?
This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.